Jill Kolesar & Lee Vermeulen

Professors, University of Kentucky

University of Kentucky
Authors

Influencer Of

Popular Content

US Food and Drug Administration REMS Program

AccessPharmacy Channel, AccessPharmacy Drug of the Week

US Food and Drug Administration REMS Program

Jill Kolesar & Lee Vermeulen

Mar 18, 2019

Drug Card Scavenger Hunt March 2019 Week # 4

AccessPharmacy Channel, Drug Card Scavenger Hunt

Drug Card Scavenger Hunt March 2019 Week # 4

Jill Kolesar & Lee Vermeulen

Mar 25, 2019

First FDA Approval for Post-Partum Depression

AccessPharmacy Channel, AccessPharmacy Drug of the Week

First FDA Approval for Post-Partum Depression

Jill Kolesar & Lee Vermeulen

Mar 25, 2019

Updated Beers Criteria Guiding Medication Use in Elderly

AccessPharmacy Channel, AccessPharmacy Drug of the Week

Updated Beers Criteria Guiding Medication Use in Elderly

Jill Kolesar & Lee Vermeulen

Feb 18, 2019

New Liquid Colchicine Dosage Form

AccessPharmacy Channel, AccessPharmacy Drug of the Week

New Liquid Colchicine Dosage Form

Jill Kolesar & Lee Vermeulen

Mar 04, 2019

Drug Card Scavenger Hunt November 2018 Week # 4

AccessPharmacy Channel, Drug Card Scavenger Hunt

Drug Card Scavenger Hunt November 2018 Week # 4

Jill Kolesar & Lee Vermeulen

Nov 26, 2018

First New Flu Antiviral Approved in 20 Years

AccessPharmacy Channel, AccessPharmacy Drug of the Week

First New Flu Antiviral Approved in 20 Years

Jill Kolesar & Lee Vermeulen

Jan 30, 2019

Opioid Epidemic Increases Number of Organ Donors Dying From Drug Overdose

AccessPharmacy Channel, AccessPharmacy Drug of the Week

Opioid Epidemic Increases Number of Organ Donors Dying From Drug Overdose

Jill Kolesar & Lee Vermeulen

Feb 10, 2019

Topics

Channels contributed to:

AccessPharmacy Channel AccessPharmacy Drug of the Week Drug Card Scavenger Hunt

Recent Comments

Jill Kolesar & Lee Vermeulen

Mar 14, 2019

Great question! REMS or "Risk Evaluation and Mitigation Strategies" is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with se...

FDA Approves Ketamine-Like Drug for Treatment of Depression